http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2121447-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7459adb4624a70d872741b999dba8ee4
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165
filingDate 1971-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1972-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber FR-2121447-A2
titleOfInvention Beta-adrenergic blocking aryloxy-prop - anolamines
abstract Beta-adrenergic blocking aryloxy-propanolamines Title cpds. of formula (I): (where -NR'R" is t-butylamino, isopropylamino, morpholino or dimethylaminoethyl), their opticallyl active isomers and their acid addition salts with pharmaceutically acceptable acids, some of which have no cardiodepressive effects at beta-blocking dosages and lack local-anaesthetic activity, are prepd. by reacting hydroxybenzamides with epichlorohydrin and reacting the resulting (2,3-epoxy-propoxy)-benzamides with HNR'R".
priorityDate 1971-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-1236523-B
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419748466
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7835
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12548678
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474861
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520497
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5147

Total number of triples: 19.